Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)

Condition:   Relapsing Multiple Sclerosis Interventions:   Drug: Evobrutinib;   Drug: Placebo (match to Teriflunomide);   Drug: Teriflunomide;   Drug: Placebo (match to Evobrutinib) Sponsors:   Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany;   EMD Serono Research & Development Institute, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials